Sjogrens Syndrome Market
- 2026 年市場規模
- USD 266 Mn
- 2033 年預估規模
- USD 331 Mn
- 年複合成長率 CAGR
- 3.2%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Sjogrens Syndrome Market, By Drug (Antimalarial Quinolines, Cholinergic Agonists, Corticosteroids, Others (Pain Relief Medication and late phase drug)), By Type (Primary, Secondary), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
報告摘要
Sjogren’s syndrome is systematic autoimmune disorder which effect the entire body, along with complication such as, chronic pain, major organ involvement, profound fatigue, neuropathies and Sjogren’s syndrome zmphomas.
For the treatment of Sjogren’s syndrome different medication such as methotrexate available to manage the syndrome. Currently no single medication has been conclusively proven to treat the progression of Sjogren’s.
Antimalarial Quinolines, Cholinergic Agonists and Corticosteroids are the prescription drug used for the treatment of Sjogren’s.
Market Dynamics
Increasing prevalence of Sjogren’s syndrome is expected to drive the market growth during the forecast period.
For instance, according to the Sjogren’s Foundation 2021, around 3 to 4 million people in the U.S. suffer from Sjogren’s syndrome which is as common as rheumatoid arthritis (RA), and three times as common as systemic lupus erythematosus (SLE).
Key features of the study
• This report provides an in-depth analysis of the global sjogren’s syndrome market, market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global sjogren’s syndrome Market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include ADVANZ Pharma, Bristol Myers Squibb, Daiichi Sankyo, GlaxoSmithKline, Novartis/MorphoSys, RemeGen, Resolve Therapeutics, Tear Solutions, VIELABIO, Otsuka Pharmaceutical Co., Ltd., and Bridge Pharma Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global sjogren’s syndrome Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sjogren’s syndrome Market
Sjogren’s Syndrome Market Segmentation
• By Drug Insights (Revenue, USD Mn, 2020 - 2033)
o Antimalarial Quinolines
o Cholinergic Agonists
o Corticosteroids
o Others (Pain Relief Medication and late phase drug)
• By Type Insights (Revenue, USD Mn, 2020 - 2033)
o Primary
o Secondary
• By Distribution Channel Insights (Revenue, USD Mn, 2020 - 2033)
o Hospital Pharmacy
o Retail Pharmacy
o Online Pharmacy
• By Region Insights (Revenue, USD Mn, 2020 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East & Africa
GCC Countries
Israel
Rest of Middle East & Africa
• Key Players in the Sjogren’s Syndrome Market
o ADVANZ Pharma
o Bristol Myers Squibb
o Daiichi Sankyo
o GlaxoSmithKline
o Novartis
o MorphoSys
o RemeGen
o Resolve Therapeutics
o Tear Solutions
o VIELABIO
o Otsuka Pharmaceutical Co., Ltd.
o Bridge Pharma Inc.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Drug
Market Snippet, By Type
Market Snippet, By Distribution Channel
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Drivers
o Restraints
o Opportunities
o Impact Analysis
o Key Development Strategies
o Mergers And Acquisition Scenario
o Market Trends
o Brand Analysis
o Regulatory Scenario
o PEST Analysis
o Pricing Analysis
o Pipeline Analysis
4. Global Sjogren’s syndrome Market, By Drug, 2020 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2020 and 2033 (%)
Y-o-Y Growth Analysis, 2020–2033
Segment Trends
o Antimalarial Quinolines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (USD Mn)
o Cholinergic Agonists
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (USD Mn)
o Corticosteroids
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (USD Mn)
o Others (Pain Relief Medication and late phase drug)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (USD Mn)
5. Global Sjogren’s Syndrome Market, By Type, 2020 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2020 and 2033 (%)
Y-o-Y Growth Analysis, 2020–2033
Segment Trends
o Primary
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (USD Mn)
o Secondary
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (USD Mn)
6. Global Sjogren’s Syndrome Market, By Distribution Channel, 2020 – 2033, (USD Mn)
o Introduction
Market Share Analysis, 2020 and 2033 (%)
Y-o-Y Growth Analysis, 2020–2033
Segment Trends
o Hospital Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (USD Mn)
o Retail Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (USD Mn)
o Online Pharmacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020 – 2033, (USD Mn)
7. Global Sjogren’s Syndrome Market, By Region, 2020 – 2033, (USD Mn)
o Introduction
Market Share Analysis, By Region, 2020 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2020–2033
o North America
Market Size and Forecast, By Drug, 2020 – 2033, (USD Mn)
Market Size and Forecast, By Type, 2020 – 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2020 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2020 – 2033, (USD Mn)
o U.S.
o Canada
o Latin America
Market Size and Forecast, By Drug, 2020 – 2033, (USD Mn)
Market Size and Forecast, By Type, 2020 – 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2020 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2020 – 2033, (USD Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Market Size and Forecast, By Drug, 2020 – 2033, (USD Mn)
Market Size and Forecast, By Type, 2020 – 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2020 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2020 – 2033, (USD Mn)
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Drug, 2020 – 2033, (USD Mn)
Market Size and Forecast, By Type, 2020 – 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2020 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2020 – 2033, (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Market Size and Forecast, By Drug, 2020 – 2033, (USD Mn)
Market Size and Forecast, By Type, 2020 – 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2020 – 2033, (USD Mn)
Market Size and Forecast, By Country, 2020 – 2033, (USD Mn)
o GCC
o Israel
o Rest of Middle East
o Africa
Market Size and Forecast, By Drug, 2020 – 2033, (USD Mn)
Market Size and Forecast, By Type, 2020 – 2033, (USD Mn)
Market Size and Forecast, By Distribution Channel, 2020 – 2033, (USD Mn)
Market Size and Forecast, By Region/Country, 2020 – 2033, (USD Mn)
o South Africa
o Central Africa
o North Africa
8. Competitive Landscape
o Competitive Snapshot
ADVANZ Pharma
o Company Overview
o Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Bristol Myers Squibb
o Company Overview
o Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Daiichi Sankyo
o Company Overview
o Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
GlaxoSmithKline
o Company Overview
o Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Novartis/MorphoSys
o Company Overview
o Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
RemeGen
o Company Overview
o Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Resolve Therapeutics
o Company Overview
o Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
TearSolutions
o Company Overview
o Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
VIELABIO
o Company Overview
o Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Otsuka Pharmaceutical Co., Ltd.
o Company Overview
o Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Bridge Pharma Inc.
o Company Overview
o Type Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
9. Section
o References
o Research Methodology
o About us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們